Health technology brand Hilo, developed by Aktiia, has launched its Hilo Core blood pressure monitoring system in the US.
Following TYBR’s B3 GEL’s US launch in January 2026, the company primarily intends to use the funds to expand market access to the hydrogel.
Under the deal, Personalis’ minimal residual disease (MRD) test will be integrated into Tempus’ broader oncology portfolio.
Cardinal Health’s acquisitions of Strive Medical and Adapt Health’s diabetes unit are collectively intended to support its at-home care business’s growth strategy.
Fresenius Medical Care has introduced TherapyWise, a cloud-based analytics platform aimed at supporting hospital and critical care teams overseeing KRT in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results